Lakshmi Padgett

833 total citations
19 papers, 608 citations indexed

About

Lakshmi Padgett is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Lakshmi Padgett has authored 19 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 10 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Lakshmi Padgett's work include Inflammatory Bowel Disease (14 papers), Microscopic Colitis (8 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Lakshmi Padgett is often cited by papers focused on Inflammatory Bowel Disease (14 papers), Microscopic Colitis (8 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Lakshmi Padgett collaborates with scholars based in United States, Canada and Australia. Lakshmi Padgett's co-authors include James C. Torner, Elliot S. Barnathan, Harold P. Adams, Mark B. Effron, Werner Hacke, Judith Frayne, Antoni Dávalos, Philip Teal, Jacques Leclerc and Barry S. Oemar and has published in prestigious journals such as Gastroenterology, Stroke and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Lakshmi Padgett

18 papers receiving 587 citations

Peers

Countries citing papers authored by Lakshmi Padgett

Since Specialization

Citations

This map shows the geographic impact of Lakshmi Padgett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lakshmi Padgett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lakshmi Padgett more than expected).

Fields of papers citing papers by Lakshmi Padgett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lakshmi Padgett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lakshmi Padgett. The network helps show where Lakshmi Padgett may publish in the future.

Co-authorship network of co-authors of Lakshmi Padgett

This figure shows the co-authorship network connecting the top 25 collaborators of Lakshmi Padgett. A scholar is included among the top collaborators of Lakshmi Padgett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lakshmi Padgett. Lakshmi Padgett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn’s Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study 2021 ·Journal of Crohn s and Colitis ·Joel R. Rosh, Dan Turner, Anne M. Griffiths, Stanley A. Cohen, (unknown), Omoniyi J. Adedokun, Lakshmi Padgett, Natalie A. Terry, Christopher O’Brien, Jeffrey S. Hyams	44
2	615 PHARMACOKINETICS OF USTEKINUMAB IN CHILDREN AND ADOLESCENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM UNISTAR, A PHASE 1 STUDY 2020 ·Gastroenterology ·Omoniyi J. Adedokun, Jeffrey S. Hyams, Dan Turner, Anne M. Griffiths, Natalie A. Terry, Lakshmi Padgett, (unknown), Christopher D. O’Brien, Joel R. Rosh	1
3	DOP71 Efficacy, safety, and tolerability of ustekinumab in paediatric patients with moderately to severely active Crohn’s disease: Results from, UniStar, a phase 1 study 2020 ·Journal of Crohn s and Colitis ·Joel R. Rosh, Dan Turner, Anne M. Griffiths, (unknown), Omoniyi J. Adedokun, Lakshmi Padgett, Natalie A. Terry, Chris O’Brien, Jeffrey S. Hyams	1
4	1164 EFFICACY, SAFETY, TOLERABILITY OF USTEKINUMAB IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM UNISTAR, A PHASE 1 STUDY 2020 ·Gastroenterology ·Joel R. Rosh, Dan Turner, Anne M. Griffiths, (unknown), Omoniyi J. Adedokun, Lakshmi Padgett, Natalie A. Terry, Christopher D. O’Brien, Jeffrey S. Hyams	1
5	Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results 2020 ·Crohn s & Colitis 360 ·Jeffrey S. Hyams, Christopher D. O’Brien, Lakshmi Padgett, Joel R. Rosh, Dan Turner, (unknown), Anne M. Griffiths, Melvin B. Heyman, Ghassan Wahbeh, Omoniyi J. Adedokun, Richard Strauß, John P. Lynch, Daphne Chan	6
6	Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension 2018 ·Journal of Crohn s and Colitis ·Walter Reinisch, Peter G. Gibson, William J. Sandborn, Brian G. Feagan, Richard Strauß, Jewel Johanns, Lakshmi Padgett, Omoniyi J. Adedokun, Jean‐Frédéric Colombel, Judith Collins, Paul Rutgeerts, Dino Tarabar, Colleen Marano	23
7	Subcutaneous Golimumab in Pediatric Ulcerative Colitis 2017 ·Inflammatory Bowel Diseases ·Jeffrey S. Hyams, Daphne Chan, Omoniyi J. Adedokun, Lakshmi Padgett, Dan Turner, Anne M. Griffiths, (unknown), Melvin B. Heyman, Joel R. Rosh, Ghassan Wahbeh, Richard Strauß	31
8	Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 Year 2016 ·Clinical and Translational Gastroenterology ·Peter G. Gibson, Brian G. Feagan, William J. Sandborn, Colleen Marano, Richard Strauß, Jewel Johanns, Lakshmi Padgett, Judith Collins, Dino Tarabar, (unknown), Paul Rutgeerts, Walter Reinisch	34
9	631 A Multi-Center Open-Label Study Assessing Pharmacokinetics, Efficacy, and Safety of Subcutaneous Golimumab in Pediatric Patients With Moderately-Severely Active Ulcerative Colitis 2016 ·Gastroenterology ·Jeffrey S. Hyams, Anne M. Griffiths, Gigi Veereman, Dan Turner, Daphne Chan, Omoniyi J. Adedokun, Lakshmi Padgett, (unknown)	2
10	Mo1790 Safety, Efficacy, and Pharmacokinetics of Golimumab in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT-SC Long term Extension 2016 ·Gastroenterology ·Walter Reinisch, Peter G. Gibson, William J. Sandborn, Brian G. Feagan, Colleen Marano, (unknown), Jewel Johanns, Hongyan Zhang, Lakshmi Padgett, Omoniyi J. Adedokun, Jean–Frédéric Colombel, Judith Collins, Paul Rutgeerts, Dino Tarabar	1
11	Su1923 Pharmacokinetics and Exposure-Response Relationships of Golimumab in Pediatric Patients With Moderate to Severe Ulcerative Colitis: Results From a Multicenter Open Label Study 2016 ·Gastroenterology ·Omoniyi J. Adedokun, Daphne Chan, Lakshmi Padgett, (unknown), Jeffrey S. Hyams, Dan Turner, Zhenhua Xu, Hugh M. Davis, (unknown)	1
12	Randomised clinical trial: a placebo‐controlled study of intravenous golimumab induction therapy for ulcerative colitis 2015 ·Alimentary Pharmacology & Therapeutics ·P. Rutgeerts, Brian G. Feagan, Colleen Marano, Lakshmi Padgett, Richard Strauß, Jewel Johanns, Omoniyi J. Adedokun, Cynthia Guzzo, (unknown), (unknown), Walter Reinisch, Peter G. Gibson, William J. Sandborn, (unknown)	66
13	OP009 Long-term safety and efficacy of golimumab in patients with moderately to severely active ulcerative colitis: Results from the PURSUIT-SC Maintenance study extension 2014 ·Journal of Crohn s and Colitis ·Walter Reinisch, Peter G. Gibson, William J. Sandborn, Brian G. Feagan, Colleen Marano, Richard Strauss, Jewel Johanns, (unknown), Lakshmi Padgett, (unknown), Judith Collins, P. Rutgeerts	1
14	Pharmacokinetics of Infliximab in Children with Moderate-to-Severe Ulcerative Colitis 2013 ·Inflammatory Bowel Diseases ·Omoniyi J. Adedokun, Zhenhua Xu, Lakshmi Padgett, Marion Blank, Jewel Johanns, Anne M. Griffiths, Joyce Ford, Honghui Zhou, Cynthia Guzzo, Hugh M. Davis, Jeffrey S. Hyams	66
15	Practical Statistical Methods: A SAS Programming Approach 2011 ·Lakshmi Padgett	5
16	Practical Statistical Methods 2011 ·Lakshmi Padgett	7
17	Treating Patients With ‘Wake-Up’ Stroke 2008 ·Stroke ·Harold P. Adams, Enrique C. Leira, James C. Torner, Elliot S. Barnathan, Lakshmi Padgett, Mark B. Effron, Werner Hacke	53
18	Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial 2007 ·Stroke ·Harold P. Adams, Mark B. Effron, James C. Torner, Antoni Dávalos, Judith Frayne, Philip Teal, Jacques Leclerc, Barry S. Oemar, Lakshmi Padgett, Elliot S. Barnathan, Werner Hacke	260
19	Delivery after Previous Caesarean Section 1973 ·Journal of the Royal Army Medical Corps ·Lakshmi Padgett	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact